R.H. Bluestein & Co’s Leidos LDOS Stock Holding History

R.H. Bluestein & Co’s Portfolio LDOS Stock Details LDOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,836	Closed	-$789K	–	355
2022 Q2	$789K	Buy	7,836 +3,200	+69%	+$332K	0.05%	120
2022 Q1	$501K	Buy	+4,636	New	+$447K	0.02%	188
2020 Q3	–	Sell	-3,836	Closed	-$359K	–	359
2020 Q2	$359K	Buy	+3,836	New	+$378K	0.02%	199

Other funds holding LDOS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

R.H. Bluestein & Co's LDOS Position: Q3 2022 in Review

R.H. Bluestein & Co sold out of Leidos (LDOS) in Q3 2022, closing a stake of 7,836 shares — an estimated $789K sold.

R.H. Bluestein & Co first reported a position in LDOS in Q2 2020 and held it in 3 quarters. The position peaked at $789K in Q2 2022. 539 funds tracked by Wall St. Rank hold LDOS as of Q3 2022.

R.H. Bluestein & Co reported no remaining Leidos position as of Q3 2022 after selling out during the quarter.
R.H. Bluestein & Co sold 7,836 Leidos shares in Q3 2022, an estimated $789K.
R.H. Bluestein & Co first reported a position in Leidos in Q2 2020 and held it in 3 quarters.
R.H. Bluestein & Co's Leidos position peaked at $789K in Q2 2022.
539 funds tracked by Wall St. Rank held Leidos as of Q3 2022.

Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.